19 results
8-K
EX-3.2
THRX
Theseus Pharmaceuticals Inc
14 Feb 24
Completion of Acquisition or Disposition of Assets
10:44am
contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.
Section 5.14 Signature Authority. Unless
SC TO-T/A
EX-99
Concentra Merger Sub II, Inc.
14 Feb 24
Third party tender offer statement (amended)
10:35am
no obligation to act on behalf of the Holders except as expressly provided herein and in the Representative Engagement Agreement, and for purposes … Engagement Agreement shall be binding upon each Holder and such Holder’s successors as if expressly confirmed and ratified in writing by such Holder
SC TO-T/A
EX-99
THRX
Theseus Pharmaceuticals Inc
30 Jan 24
Third party tender offer statement (amended)
8:23am
and the Transactions. In connection with this engagement, the Theseus Board requested that Leerink Partners evaluate the fairness, from a financial point of view
SC 14D9
THRX
Theseus Pharmaceuticals Inc
10 Jan 24
Tender offer solicitation
9:47am
and operations.
On May 26, 2023, the Company entered into an engagement letter with its financial advisor Leerink Partners LLC (“Leerink Partners”), who … , the Company entered into an amended and restated engagement letter with Leerink Partners (the “Leerink Engagement Letter”) regarding Leerink Partners
SC TO-T
EX-99
THRX
Theseus Pharmaceuticals Inc
10 Jan 24
Third party tender offer statement
8:51am
with this engagement, the Theseus Board requested that Leerink Partners evaluate the fairness, from a financial point of view, to the holders of Shares (other than
8-K
EX-2.1
obly6t
22 Dec 23
Entry into a Material Definitive Agreement
6:36am
8-K
EX-10.2
zp04hu
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.4
nezdi
4 Dec 23
Departure of Directors or Certain Officers
6:30am
8-K
EX-10.1
fdunp75jfv4xm9
13 Nov 23
Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives
4:06pm
PRE 14A
8exeg
14 Apr 23
Preliminary proxy
9:00am
DEF 14A
1t7s4ib2c p4k5hm5a
25 Apr 22
Definitive proxy
4:30pm
424B4
cq251nfe
7 Oct 21
Prospectus supplement with pricing info
5:03pm
S-1/A
4qg c21mn4u644qm
30 Sep 21
IPO registration (amended)
6:33am
S-1/A
EX-10.1
s2yv8oybl1y l7sfo
30 Sep 21
IPO registration (amended)
6:33am
S-1
dldbv 5xhp0bze5
15 Sep 21
IPO registration
4:04pm
DRS/A
f1j1p17xwg08x18m7q6
23 Aug 21
Draft registration statement (amended)
12:00am
DRS
6e4zfjsf6k019v53n3
20 Jul 21
Draft registration statement
12:00am
- Prev
- 1
- Next